NSC vs PTHS · P/E 18, rev $6.46B vs rev $16.8M
Norfolk Southern Corporation (NSC) versus Pelthos Therapeutics Inc. (PTHS) — a side-by-side from cached financials, not a winner call.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
NSC currently screens at market cap $60.10B and trailing P/E 18.2. PTHS currently screens at market cap $94.7M.
Not investment advice. Open the NSC and PTHS stock pages for the full models.
Not investment advice.